Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


While you were sleeping: Iraq concern weighs on stocks

While you were sleeping: Iraq concern weighs on stocks

June 25 (BusinessDesk) – Wall Street declined as Iraq’s violence escalated into cross-border hostilities with Syria, bolstering concern about the stability of the Middle East and overshadowing better-than-expected data on US consumer confidence and new home sales.

The Wall Street Journal reported that Syrian warplanes struck targets in western Iraq, killing at least 50 people.

In the final hour of trading in New York, the Dow Jones Industrial Average shed 0.48 percent, while the Standard & Poor’s 500 Index slipped 0.10 percent. The Nasdaq Composite Index rose 0.31 percent.

Declines in shares of Exxon Mobil, down 1.2 percent, and those of JPMorgan Chase, down 1.1 percent, led the Dow lower.

“It’s the situation with any kind of geopolitical scenario over in the Middle East,” Stephen Carl, principal and head equity trader at New York-based Williams Capital Group, told Bloomberg News. “It’s tenuous, you don’t know which way it’s going to go, and any kind of abrupt action is going to be a trigger.”

The latest US economic data underpinned the view of a sustained recovery.

New home sales jumped 18.6 percent to a seasonally adjusted annual rate of 504,000 units in May, according to Commerce Department data. Separately, the Conference Board’s consumer confidence index climbed to 85.2 in June, the highest reading since January 2008, and up from 82.2 in May.

“This is convincing evidence that the economy continues to expand," Chris Rupkey, chief financial economist at Bank of Tokyo-Mitsubishi UFJ in New York, told Reuters. "It takes a lot of confidence to buy the biggest of big ticket items consumers ever face, buying a new home."

To be sure, the S&P/Case-Shiller index of property values rose 10.8 percent from April 2013, the smallest 12-month increase in more than a year.

Shares of Vertex Pharmaceuticals soared, last up 40.5 percent, after the biotech company said trials showed promising results in improving lung function for people with cystic fibrosis.

"The combination of lumacaftor and ivacaftor is the first regimen designed to address the underlying cause of CF for people with the most common form of the disease, and based on these data, we plan to move as fast as possible to submit applications for approval of this combination regimen in countries around the world," Jeffrey Chodakewitz, chief medical officer at Vertex, said in a statement.

In Europe, the Stoxx 600 Index finished the day with a 0.2 percent decline from the previous close, as did the UK’s FTSE 100. France’s CAC 40 eked out a 0.06 percent gain, while Germany’s DAX rose 0.2 percent.

In Germany, the Ifo institute’s business climate index slid to 109.7 in June from 110.4 in May.

The British pound fell after Bank of England Governor Mark Carney suggested interest rates might not rise as soon as thought by pointing to the fact that wages were not rising as quickly as the central bank had anticipated. It was Carney himself who earlier this month sparked expectations of a potential rate increase this year.

"An early rate hike may not be a done deal as yet," Valentin Marinov, head of G10 currency strategy at Citi, told Reuters.

(BusinessDesk)

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Fonterra: Canpac Site 'Resize' To Focus More On Paediatrics

Fonterra is looking at realigning its packing operations at Canpac, in the Waikato, to focus more on paediatric nutritionals... The proposed changes could mean around 110 roles may not be required at the site which currently employs 330. More>>

ALSO:

Scoop Business: Postie Plus Brand Gets 2nd Chance With Well-Funded Pepkor

The Postie Plus brand is getting a new lease of life after South Africa’s Pepkor bought the failed retailer’s assets out of administration and said it will use its purchasing power to reduce costs of stock and fatten margins. More>>

ALSO:

Warming: Warming Signs From State Of Climate Report

Climate data from air, land, sea and ice in 2013 'reflect trends of a warming planet' -- says the latest State of the Climate report, launched by U.S. and New Zealand scientists. More>>

ALSO:

Scoop Business: Embrace Falling Home Affordability, Says NZIER

Despair over the inability to afford a house is misplaced and should be embraced as an opportunity to invest in more wealth-creating activity, says the principal economist at the New Zealand Institute of Economic Research, Shamubeel Eaqub. More>>

Productivity Commission: NZ Regulation Not Keeping Pace

New Zealand regulators often have to work with out-of-date legislation, quality checks are under strain, and regulatory workers need better training and development. More>>

ALSO:

Callaghan Innovation: Investment To Help Deepen Innovation Reporting

Callaghan Innovation, the government’s high tech HQ for Kiwi business, is to help deepen New Zealand media coverage of the commercialisation of innovation through an arms-length partnership with independent business news service BusinessDesk. More>>

ALSO:

Tax Credits, Grants: Greens $1Bn R&D Plan

In the Party’s headline economic announcement, the Greens have launched their plan to build a smarter, more innovative economy which has as its centrepiece an additional $1 billion of government investment in research and development (R&D) above current spend, including tax breaks for business. More>>

ALSO:

Inflation: CPI Increases 0.3 Percent In June Quarter

The consumers price index (CPI) rose 0.3 percent in the June 2014 quarter, Statistics New Zealand said today. This follows rises of 0.3 percent the March quarter and 0.1 percent in the December 2013 quarter. More>>

ALSO:

Get More From Scoop

 
 
Computer Power Plus

Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news